These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 9004358
1. Efficacy of agents counteracting hypoxia in fractionated radiation regimes. Stern S, Guichard M. Radiother Oncol; 1996 Nov; 41(2):143-9. PubMed ID: 9004358 [Abstract] [Full Text] [Related]
2. Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration. Thomas CD, Stern S, Chaplin DJ, Guichard M. Radiother Oncol; 1996 Jun; 39(3):235-41. PubMed ID: 8783400 [Abstract] [Full Text] [Related]
3. Comparison of two techniques for detecting tumour hypoxia: a fluorescent immunochemical method and an in vitro colony assay. Stern S, Hodgkiss RJ, Guichard M. Radiother Oncol; 1996 May; 39(2):129-35. PubMed ID: 8735480 [Abstract] [Full Text] [Related]
4. Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours. Simon JM, Lartigau E, Guichard M. Radiother Oncol; 1993 Sep; 28(3):203-7. PubMed ID: 8255997 [Abstract] [Full Text] [Related]
5. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Rojas A, Hirst VK, Calvert AS, Johns H. Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):357-65. PubMed ID: 8567336 [Abstract] [Full Text] [Related]
6. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts. Thomas CD, Chavaudra N, Martin L, Guichard M. Radiat Res; 1994 Jul 15; 139(1):1-8. PubMed ID: 8016297 [Abstract] [Full Text] [Related]
7. Nicotinamide and carbogen: relationship between pO2 and radiosensitivity in three tumour lines. Martin LM, Thomas CD, Guichard M. Int J Radiat Biol; 1994 Mar 15; 65(3):379-86. PubMed ID: 7908317 [Abstract] [Full Text] [Related]
12. Tumour oxygenation, radiosensitivity, and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration. Thomas CD, Prade M, Guichard M. Int J Radiat Biol; 1995 May 15; 67(5):597-605. PubMed ID: 7775835 [Abstract] [Full Text] [Related]
13. Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia. Horsman MR, Grau C, Overgaard J. Acta Oncol; 1995 May 15; 34(3):325-8. PubMed ID: 7779417 [Abstract] [Full Text] [Related]
14. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Horsman MR, Nordsmark M, Khalil AA, Hill SA, Chaplin DJ, Siemann DW, Overgaard J. Acta Oncol; 1994 May 15; 33(4):371-6. PubMed ID: 8018368 [Abstract] [Full Text] [Related]
16. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation. el-Said A, Menke D, Dorie MJ, Brown JM. Radiat Oncol Investig; 1999 May 15; 7(3):163-9. PubMed ID: 10406058 [Abstract] [Full Text] [Related]
18. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing. Teicher BA, Sotomayor EA, Dupuis NP, Kusumoto T, Menon K. J Cancer Res Clin Oncol; 1994 May 15; 120(10):593-8. PubMed ID: 7929530 [Abstract] [Full Text] [Related]
20. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. Horsman MR. Acta Oncol; 1995 May 15; 34(5):571-87. PubMed ID: 7546822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]